<DOC>
	<DOCNO>NCT01126528</DOCNO>
	<brief_summary>This study randomize placebo-controlled trial oral weekly vitamin D3 ( cholecalciferol ) supplementation third trim pregnancy among woman Dhaka , Bangladesh . The overall goal study establish whether evidence improve vitamin D status among pregnant woman Bangladesh enhance resistance infant offspring infection . The aim study assess effect supplementation 1 ) maternal infant vitamin D status ( base blood concentration vitamin D metabolite ) , 2 ) marker neonatal immune function .</brief_summary>
	<brief_title>Antenatal Vitamin D3 Supplementation Bangladesh : Randomized Controlled Trial</brief_title>
	<detailed_description>The primary aim study : AIM # 1 - To assess effect weekly antenatal administration oral vitamin D3 ( 875 mcg/week = 35,000 IU week â‰ˆ 5,000 IU per day ) start third trimester ( 26-29 week gestation ) maternal vitamin D status fetal-neonatal vitamin D status ( cord blood ) , comparison placebo control supplement . AIM # 2 - To demonstrate maternal fetal safety weekly maternal antenatal ( second third-trimester ) vitamin D supplementation dose 875 mcg/week monitoring maternal serum calcium , urinary calcium excretion , cord blood calcium concentration , newborn clinical parameter . AIM # 3 - To measure effect antenatal vitamin D supplementation select biomarkers fetal-neonatal immune function cord blood : vitro stimulate cord blood mononuclear cell ( CBMC ) LL-37 expression , gene expression relate inflammatory immunoregulatory pathway , Th1/Th2 cytokine secretion , bactericidal property .</detailed_description>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<mesh_term>Ergocalciferols</mesh_term>
	<mesh_term>Cholecalciferol</mesh_term>
	<criteria>Women age 18 &lt; 35 year . Current residence Dhaka fix address Plans delivery perform Shimantik maternity center , stay Dhaka throughout pregnancy least one month past date delivery . Gestational age 26th 29th ( inclusive ) , estimate base first day last menstrual period ( LMP ) . Use dietary supplement contain 400 IU/day ( 10 mcg/day ) vitamin D within month prior enrolment , refusal stop take supplemental vitamin D dose enrollment . Current use anticonvulsant antimycobacterial ( tuberculosis ) medication . Severe anemia ( hemoglobin concentration &lt; 70 g/L ) . Complicated medical obstetric history may increase risk preterm birth labor/delivery complication , base selfreport clinical assessment physician ( e.g. , cardiovascular disease , uterine hemorrhage , placenta previa , threaten abortion , hypertension , preeclampsia , preterm labor , multiple gestation ) . Prior history delivery infant major congenital anomaly , birth asphyxia , perinatal death ( stillbirth death within first week life ) .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>34 Years</maximum_age>
	<verification_date>August 2012</verification_date>
	<keyword>Vitamin D</keyword>
	<keyword>cholecalciferol</keyword>
	<keyword>Micronutrients</keyword>
	<keyword>Developing country</keyword>
	<keyword>Bangladesh</keyword>
	<keyword>Infant , Newborn</keyword>
	<keyword>Reproductive Health</keyword>
	<keyword>Infant , Newborn , Diseases</keyword>
	<keyword>Perinatology</keyword>
	<keyword>Immunology</keyword>
	<keyword>cathelicidin</keyword>
	<keyword>Maternal Nutrition Physiology</keyword>
</DOC>